SCM
BIVV

Sarissa Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Sarissa Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,165,000
Closed -$62.8M – 12
2017
Q4 		$62.8M Buy
+1,165,000
New +$63.7M 16.08% 2
2017
Q2 		– Sell
-155,000
Closed -$8.44M – 11
2017
Q1 		$8.44M Buy
+155,000
New +$7.63M 3.34% 5

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Sarissa Capital Management's BIVV Position: Q1 2018 in Review

Sarissa Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,165,000 shares — an estimated $62.8M sold.

Sarissa Capital Management first reported a position in BIVV in Q1 2017 and held it in 2 quarters. The position peaked at $62.8M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Sarissa Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Sarissa Capital Management sold 1,165,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $62.8M.
  • Sarissa Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Sarissa Capital Management's Bioverativ Inc. Common Stock position peaked at $62.8M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Sarissa Capital Management's 13F filing for Q1 2018, filed 15 May 2018.